ID

37204

Descripción

Safety Study of Ragweed-SPIRE in Subjects With Ragweed Allergies and Asthma; ODM derived from: https://clinicaltrials.gov/show/NCT02061670

Link

https://clinicaltrials.gov/show/NCT02061670

Palabras clave

Versiones (1)
  1. 7/7/19 7/7/19 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

7 de julio de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Seasonal Allergic Rhinitis NCT02061670

Inglés

Eligibility Seasonal Allergic Rhinitis NCT02061670

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
male or female, aged 18-65 years.
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
asthma treated by inhaled saba or inhaled saba plus low-medium dose ics in 6 weeks prior to randomisation.
Descripción

Asthma | Inhalation beta2-Adrenergic Agonist Short-term Active | Inhaled steroids Low dose

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0004096
UMLS CUI [2,1]
C0205535
UMLS CUI [2,2]
C2917450
UMLS CUI [2,3]
C0443303
UMLS CUI [2,4]
C0205177
UMLS CUI [3,1]
C2065041
UMLS CUI [3,2]
C0445550
a reliable history consistent with moderate to severe rhinoconjunctivitis on exposure to ragweed for at least the previous two ragweed seasons.
Descripción

Medical History Consistent with Rhinoconjunctivitis Moderate | Medical History Consistent with Rhinoconjunctivitis Severe | Exposure to Ragweed | Ragweed Seasons Quantity

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0262926
UMLS CUI [1,2]
C0332290
UMLS CUI [1,3]
C0861155
UMLS CUI [1,4]
C0205081
UMLS CUI [2,1]
C0262926
UMLS CUI [2,2]
C0332290
UMLS CUI [2,3]
C0861155
UMLS CUI [2,4]
C0205082
UMLS CUI [3,1]
C0332157
UMLS CUI [3,2]
C0440357
UMLS CUI [4,1]
C0440357
UMLS CUI [4,2]
C0036497
UMLS CUI [4,3]
C1265611
positive skin prick test to ragweed
Descripción

Skin prick test Positive Ragweed

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0430561
UMLS CUI [1,2]
C1514241
UMLS CUI [1,3]
C0440357
ragweed-specific immunoglobulin e (ige) ≥ 0.35 ku/l.
Descripción

Ragweed Specific Immunoglobulin E measurement

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0440357
UMLS CUI [1,2]
C0205369
UMLS CUI [1,3]
C0202086
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
history of life-threatening asthma.
Descripción

Asthma Life Threatening

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0004096
UMLS CUI [1,2]
C2826244
uncontrolled asthma according to gina
Descripción

Asthma Uncontrolled | Initiative Global Asthma

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0004096
UMLS CUI [1,2]
C0205318
UMLS CUI [2,1]
C0424093
UMLS CUI [2,2]
C2348867
UMLS CUI [2,3]
C0004096
fev1 of < 70 % of predicted, regardless of the cause.
Descripción

Percent predicted FEV1

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0730561
administration of adrenaline (epinephrine) is contraindicated (e.g. subjects with acute or chronic symptomatic coronary heart disease or severe hypertension).
Descripción

Epinephrine Contraindicated | Coronary heart disease Symptomatic | Coronary heart disease Symptomatic chronic | Hypertension, severe

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0014563
UMLS CUI [1,2]
C1444657
UMLS CUI [2,1]
C0010068
UMLS CUI [2,2]
C0231220
UMLS CUI [3,1]
C0010068
UMLS CUI [3,2]
C0231220
UMLS CUI [3,3]
C0205191
UMLS CUI [4]
C4013784
history of severe drug allergy or anaphylactic reaction to food.
Descripción

Drug Allergy Severe | Food anaphylaxis

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0013182
UMLS CUI [1,2]
C0205082
UMLS CUI [2]
C0685898
a history of any significant disease or disorder (e.g. immune system, pulmonary, cardiovascular, gastrointestinal, liver, renal, neurological, musculoskeletal, endocrine, metabolic, malignant, psychiatric, major physical impairment, history of alcohol or drug abuse)
Descripción

Disease Significant | Immune System Disease | Lung disease | Cardiovascular Disease | Gastrointestinal Disease | Liver disease | Kidney Disease | Nervous system disorder | Musculoskeletal Disease | Endocrine System Disease | Metabolic Disease | Malignant disease | Mental disorders | Physical impairment Major | Substance Use Disorders

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0750502
UMLS CUI [2]
C0021053
UMLS CUI [3]
C0024115
UMLS CUI [4]
C0007222
UMLS CUI [5]
C0017178
UMLS CUI [6]
C0023895
UMLS CUI [7]
C0022658
UMLS CUI [8]
C0027765
UMLS CUI [9]
C0026857
UMLS CUI [10]
C0014130
UMLS CUI [11]
C0025517
UMLS CUI [12]
C0442867
UMLS CUI [13]
C0004936
UMLS CUI [14,1]
C0231171
UMLS CUI [14,2]
C0205164
UMLS CUI [15]
C0038586
Volver a la parte superior de la página

Similar models

Eligibility Seasonal Allergic Rhinitis NCT02061670

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
male or female, aged 18-65 years.
boolean
C0001779 (UMLS CUI [1])
Asthma | Inhalation beta2-Adrenergic Agonist Short-term Active | Inhaled steroids Low dose
Item
asthma treated by inhaled saba or inhaled saba plus low-medium dose ics in 6 weeks prior to randomisation.
boolean
C0004096 (UMLS CUI [1])
C0205535 (UMLS CUI [2,1])
C2917450 (UMLS CUI [2,2])
C0443303 (UMLS CUI [2,3])
C0205177 (UMLS CUI [2,4])
C2065041 (UMLS CUI [3,1])
C0445550 (UMLS CUI [3,2])
Medical History Consistent with Rhinoconjunctivitis Moderate | Medical History Consistent with Rhinoconjunctivitis Severe | Exposure to Ragweed | Ragweed Seasons Quantity
Item
a reliable history consistent with moderate to severe rhinoconjunctivitis on exposure to ragweed for at least the previous two ragweed seasons.
boolean
C0262926 (UMLS CUI [1,1])
C0332290 (UMLS CUI [1,2])
C0861155 (UMLS CUI [1,3])
C0205081 (UMLS CUI [1,4])
C0262926 (UMLS CUI [2,1])
C0332290 (UMLS CUI [2,2])
C0861155 (UMLS CUI [2,3])
C0205082 (UMLS CUI [2,4])
C0332157 (UMLS CUI [3,1])
C0440357 (UMLS CUI [3,2])
C0440357 (UMLS CUI [4,1])
C0036497 (UMLS CUI [4,2])
C1265611 (UMLS CUI [4,3])
Skin prick test Positive Ragweed
Item
positive skin prick test to ragweed
boolean
C0430561 (UMLS CUI [1,1])
C1514241 (UMLS CUI [1,2])
C0440357 (UMLS CUI [1,3])
Ragweed Specific Immunoglobulin E measurement
Item
ragweed-specific immunoglobulin e (ige) ≥ 0.35 ku/l.
boolean
C0440357 (UMLS CUI [1,1])
C0205369 (UMLS CUI [1,2])
C0202086 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Asthma Life Threatening
Item
history of life-threatening asthma.
boolean
C0004096 (UMLS CUI [1,1])
C2826244 (UMLS CUI [1,2])
Asthma Uncontrolled | Initiative Global Asthma
Item
uncontrolled asthma according to gina
boolean
C0004096 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0424093 (UMLS CUI [2,1])
C2348867 (UMLS CUI [2,2])
C0004096 (UMLS CUI [2,3])
Percent predicted FEV1
Item
fev1 of < 70 % of predicted, regardless of the cause.
boolean
C0730561 (UMLS CUI [1])
Epinephrine Contraindicated | Coronary heart disease Symptomatic | Coronary heart disease Symptomatic chronic | Hypertension, severe
Item
administration of adrenaline (epinephrine) is contraindicated (e.g. subjects with acute or chronic symptomatic coronary heart disease or severe hypertension).
boolean
C0014563 (UMLS CUI [1,1])
C1444657 (UMLS CUI [1,2])
C0010068 (UMLS CUI [2,1])
C0231220 (UMLS CUI [2,2])
C0010068 (UMLS CUI [3,1])
C0231220 (UMLS CUI [3,2])
C0205191 (UMLS CUI [3,3])
C4013784 (UMLS CUI [4])
Drug Allergy Severe | Food anaphylaxis
Item
history of severe drug allergy or anaphylactic reaction to food.
boolean
C0013182 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0685898 (UMLS CUI [2])
Disease Significant | Immune System Disease | Lung disease | Cardiovascular Disease | Gastrointestinal Disease | Liver disease | Kidney Disease | Nervous system disorder | Musculoskeletal Disease | Endocrine System Disease | Metabolic Disease | Malignant disease | Mental disorders | Physical impairment Major | Substance Use Disorders
Item
a history of any significant disease or disorder (e.g. immune system, pulmonary, cardiovascular, gastrointestinal, liver, renal, neurological, musculoskeletal, endocrine, metabolic, malignant, psychiatric, major physical impairment, history of alcohol or drug abuse)
boolean
C0012634 (UMLS CUI [1,1])
C0750502 (UMLS CUI [1,2])
C0021053 (UMLS CUI [2])
C0024115 (UMLS CUI [3])
C0007222 (UMLS CUI [4])
C0017178 (UMLS CUI [5])
C0023895 (UMLS CUI [6])
C0022658 (UMLS CUI [7])
C0027765 (UMLS CUI [8])
C0026857 (UMLS CUI [9])
C0014130 (UMLS CUI [10])
C0025517 (UMLS CUI [11])
C0442867 (UMLS CUI [12])
C0004936 (UMLS CUI [13])
C0231171 (UMLS CUI [14,1])
C0205164 (UMLS CUI [14,2])
C0038586 (UMLS CUI [15])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial